TRIM29 (Lung Squamous Cell Carcinoma Marker) Antibody
Mouse Monoclonal Antibody [Clone TRIM29/1041 ]
|Application ||IHC, IF, FC|
|Other Accession||23650, 504115|
|Isotype||Mouse / IgG2a, kappa|
|Other Names||Tripartite motif-containing protein 29, Ataxia telangiectasia group D-associated protein, TRIM29, ATDC|
|Storage||Store at 2 to 8°C.Antibody is stable for 24 months.|
|Precautions||TRIM29 (Lung Squamous Cell Carcinoma Marker) Antibody is for research use only and not for use in diagnostic or therapeutic procedures.|
|Function||It is able to complement the radiosensitivity defect of an ataxia telangiectasia (AT) fibroblast cell line.|
|Cellular Location||Cytoplasm. Note=Colocalizes with intermediate filaments|
|Tissue Location||Expressed in placenta, prostate and thymus.|
Thousands of laboratories across the world have published research that depended on the performance of antibodies from Abgent to advance their research. Check out links to articles that cite our products in major peer-reviewed journals, organized by research category.
email@example.com, and receive a free "I Love Antibodies" mug.
Provided below are standard protocols that you may find useful for product applications.
It recognizes a 66kDa protein, which is identified as Tripartite motif-containing protein 29 (TRIM29). It interacts with the intermediate filament protein vimentin, a substrate for the PKC family of protein kinases, and with hPKCI-1, an inhibitor of the PKCs. TRIM29 protein contains both zinc finger and leucine zipper motifs, suggesting that the it may form homodimers and possibly associate with DNA. High expression of TRIM29 has been reported in gastric cancer and pancreatic cancer, and correlates with enhanced tumor growth and lymph node metastasis. TRIM29 is also able to distinguish lung squamous cell carcinoma from lung adenocarcinoma with ~90% positive accuracy, when used in a panel with TTF-1, p63, CK5/6, and Napsin-A antibodies.
Kosaka Y, et al. Tripartite motif-containing 29 (TRIM29) is a novel marker for lymph node metastasis in gastric cancer. Ann Surg Oncol. 14(9): 2543-9. 2007. | Ring BZ, et al. A novel five-antibody immunohistochemical test for sub-classification of lung carcinoma. Mod Pathol. 22(8): 1032-43. 2009
If you have used an Abgent product and would like to share how it has performed, please click on the "Submit Review" button and provide the requested information. Our staff will examine and post your review and contact you if needed.
If you have any additional inquiries please email technical services at firstname.lastname@example.org.